NCT02000609View on ClinicalTrials.gov

"A Phase II, 5-way Cross-over Study to Evaluate the Pharmacodynamics of Nexthaler Dry Powder Inhaler in COPD Patients"

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

COPD

Interventions

DRUG

CHF 1535 NEXThaler 800/48

DRUG

CHF 1535 NEXThaler 200/12

DRUG

CHF 1535 NEXThaler PLACEBO

DRUG

CHF 1535 pMDI 200/12

DRUG

CHF1535 pMDI 800/48

Trial Locations (1)

M239Qz

Medicine Evaluation Unit, Manchester

All Listed Sponsors

lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT02000609 - "A Phase II, 5-way Cross-over Study to Evaluate the Pharmacodynamics of Nexthaler Dry Powder Inhaler in COPD Patients" | Biotech Hunter | Biotech Hunter